Transplantation of Declined Liver Allografts Following Normothermic Ex-Situ Evaluation

American Journal of Transplantation

Volumn 16, Issue 11, 2016, Pages 3235-3245

  Mergental, H ^a,b   Perera, M T P R ^a   Laing, R W ^b   Muiesan, P ^a   Isaac, J R ^a   Smith, A ^a   Stephenson, B T F ^b   Cilliers, H ^a   Neil, D A H ^a   Hubscher S G ^a   Afford, S C ^b   Mirza, D F ^a,b  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

clinical research practice; donors and donation: donor evaluation; donors and donation: extended criteria; liver allograft function dysfunction; liver transplantation hepatology; organ acceptance; organ perfusion and preservation; organ procurement and allocation

Indexed keywords

ALANINE AMINOTRANSFERASE; LACTIC ACID; URSODEOXYCHOLIC ACID;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; BILE; BILE DUCT INJURY; BRAIN DEATH; CLINICAL ARTICLE; CRYOPRESERVATION; FEMALE; GRAFT PRESERVATION; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; LENGTH OF STAY; LIVER BLOOD FLOW; LIVER FUNCTION TEST; LIVER GRAFT REJECTION; LIVER HISTOLOGY; LIVER PERFUSION; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; ORGAN DONOR; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; ALLOGRAFT; DONOR; EVALUATION STUDY; FOLLOW UP; GRAFT REJECTION; ISCHEMIA; LIVER; METABOLISM; ORGAN PRESERVATION; OUTCOME ASSESSMENT; PERFUSION; PILOT STUDY; PRIMARY GRAFT DYSFUNCTION; PROCEDURES; SUPPLY AND DISTRIBUTION; TISSUE SURVIVAL; TRANSPLANTATION; VASCULARIZATION;

ADULT; AGED; ALLOGRAFTS; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HUMANS; LIVER; LIVER FUNCTION TESTS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; ORGAN PRESERVATION; OUTCOME ASSESSMENT (HEALTH CARE); PERFUSION; PILOT PROJECTS; PRIMARY GRAFT DYSFUNCTION; TISSUE AND ORGAN PROCUREMENT; TISSUE DONORS; TISSUE SURVIVAL; WARM ISCHEMIA;

EID: 84978857949     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.13875     Document Type: Article

References (32)

1. Murray CJ, Richards MA, Newton JN, et al. UK health performance: Findings of the Global Burden of Disease Study 2010. Lancet 2013; 381: 997–1020.
2. Interim Report on Liver Transplantation: Report for 2014/2015. [cited 2015 Sept 1]. Available from: http://www.odt.nhs.uk.
3. OPTN/SRTR 2012 Annual Data Report: Deceased Organ Donation. [cited 2015 Oct 30]. Available from: http://srtr.transplant.hrsa.gov.
4. Williams R, Ashton K, Aspinall R, et al. Implementation of the Lancet Standing Commission on Liver Disease in the UK. Lancet 2015; 386: 2098–2111.
5. Williams R, Aspinall R, Bellis M, et al. Addressing liver disease in the UK: A blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis. Lancet 2014; 384: 1953–1997.
6. Detry O, Deroover A, Meurisse N, et al. Donor age as a risk factor in donation after circulatory death liver transplantation in a controlled withdrawal protocol programme. Br J Surg 2014; 101: 784–792.
7. Jay CL, Lyuksemburg V, Ladner DP, et al. Ischemic cholangiopathy after controlled donation after cardiac death liver transplantation: A meta-analysis. Ann Surg 2011; 253: 259–264.
8. Saidi RF, Bradley J, Greer D, et al. Changing pattern of organ donation at a single center: Are potential brain dead donors being lost to donation after cardiac death? Am J Transplant 2010; 10: 2536–2540.
9. Mirza DF, Gunson BK, Da Silva RF, Mayer AD, Buckels JA, McMaster P. Policies in Europe on “marginal quality” donor livers. Lancet 1994; 344: 1480–1483.
10. Leithead JA, Tariciotti L, Gunson B, et al. Donation after cardiac death liver transplant recipients have an increased frequency of acute kidney injury. Am J Transplant 2012; 12: 965–975.
11. Organ Donation and Transplantation: Activity Report 2014/15. [cited 2015 Oct 30]. Available from: http://www.odt.nhs.uk.
12. Ravikumar R, Jassem W, Mergental H, et al. Liver transplantation after ex vivo normothermic machine preservation: A Phase 1 (first-in-man) clinical trial. Am J Transplant 2016; DOI: 10.1111/ajt.13708.
13. Perera T, Mergental H, Stephenson B, et al. First human liver transplantation using a marginal allograft resuscitated by normothermic machine perfusion. Liver Transpl 2016; 22: 120–124.
14. Stephenson B, Widmer J, Laing R, et al. Normothermic machine liver perfusion: A tool to assess the viability of human donor livers. Transpl Int 2015; 28(S4): 769.
15. National standards for organ retrieval from deceased donors (joint with NHSBT). [cited 2015 Sept 1]. Available from: http://www.bts.org.uk.
16. Silva MA, Mirza DF, Murphy N, et al. Intrahepatic complement activation, sinusoidal endothelial injury, and lactic acidosis are associated with initial poor function of the liver after transplantation. Transplantation 2008; 85: 718–725.
17. op den Dries S, Westerkamp AC, Karimian N, et al. Injury to peribiliary glands and vascular plexus before liver transplantation predicts formation of non-anastomotic biliary strictures. J Hepatol 2014; 60: 1172–1179.
18. Taking Organ Transplantation to 2020: A UK strategy. [cited 2015 Sept 1]. Available from: http://www.nhsbt.nhs.uk.
19. Ardehali A, Esmailian F, Deng M, et al. Ex-vivo perfusion of donor hearts for human heart transplantation (PROCEED II): A prospective, open-label, multicentre, randomised non-inferiority trial. Lancet 2015; 385: 2577–2584.
20. Dhital KK, Iyer A, Connellan M, et al. Adult heart transplantation with distant procurement and ex-vivo preservation of donor hearts after circulatory death: A case series. Lancet 2015; 385: 2585–2591.
21. Dutkowski P, Schlegel A, de Oliveira M, Mullhaupt B, Neff F, Clavien PA. HOPE for human liver grafts obtained from donors after cardiac death. J Hepatol 2014; 60: 765–772.
22. Warnecke G, Moradiellos J, Tudorache I, et al. Normothermic perfusion of donor lungs for preservation and assessment with the Organ Care System Lung before bilateral transplantation: A pilot study of 12 patients. Lancet 2012; 380: 1851–1858.
23. Moers C, Pirenne J, Paul A, Ploeg RJ; Machine Preservation Trial Study G. Machine perfusion or cold storage in deceased-donor kidney transplantation. N Engl J Med 2012; 366: 770–771.
24. Guarrera JV, Henry SD, Samstein B, et al. Hypothermic machine preservation in human liver transplantation: The first clinical series. Am J Transplant 2010; 10: 372–381.
25. Henry SD, Nachber E, Tulipan J, et al. Hypothermic machine preservation reduces molecular markers of ischemia/reperfusion injury in human liver transplantation. Am J Transplant 2012; 12: 2477–2486.
26. Gallinat A, Moers C, Treckmann J, et al. Machine perfusion versus cold storage for the preservation of kidneys from donors >/= 65 years allocated in the Eurotransplant Senior Programme. Nephrol Dial Transplant 2012; 27: 4458–4463.
27. Guarrera JV, Henry SD, Samstein B, et al. Hypothermic machine preservation facilitates successful transplantation of “orphan” extended criteria donor livers. Am J Transplant 2015; 15: 161–169.
28. Tariciotti L, Rocha C, Perera MT, et al. Is it time to extend liver acceptance criteria for controlled donors after cardiac death? Transplantation 2011; 92: 1140–1146.
29. DeOliveira ML, Jassem W, Valente R, et al. Biliary complications after liver transplantation using grafts from donors after cardiac death: Results from a matched control study in a single large volume center. Ann Surg 2011; 254: 716–722; discussion 22–23.
30. Watson CJ, Kosmoliaptsis V, Randle LV, et al. Preimplant normothermic liver perfusion of a suboptimal liver donated after circulatory death. Am J Transplant 2016; 16: 353–357.
31. Olthoff KM, Kulik L, Samstein B, et al. Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors. Liver Transpl. 2010; 16: 943–949.
32. Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009; 250: 187–196.